| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2011 | A cancer targeting- peptide for a broad spectrum of cancers including cancer stem cells | Chen, I. J.; Liu, I. J.; Chang, Y. J.; Chang, N. C.; Yu, J.; Lee, T. W.; Wu, H. C.; Yu, A. L. | CANCER RESEARCH | | | |
| 2007 | A primitive subpopulation of pulmonary cells functions as pulmonary stem cells and as preferential target for SARS and H5N1 virus infections. | Yu, J; Ling, T. Y; Chen, S. H; Cheng, M. C; Lee, S. H; Wu, T. J; Chien, Y. L; Cho, H. C; Kuo, M. D; Yu, A. L. | | | | |
| 1992 | Activin A-induced differentiation in K562 cells is associated with a transient hypophosphorylation of Rb protein and the concomitant block of cell cycle at G1 phase | Sehy, D. W.; Shao, L. E.; Yu, A. L.; Tsai, W. M.; Yu, J. | J. Cell. Biochem 50, 255-265 | | | |
| 2011 | Avidity of CD1d-ligand-receptor ternary complex contributes to Th1 polarization and anticancer efficacy | Wu, T. -N.; Lin, K. -H.; Chang, Y. -J.; Huang, J. -R.; Cheng, J. -Y.; Yu, A. L.; Wong, C. -H. | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 108(42), 17275-17280 | | | |
| 2008 | BO-0742, a derivative of AHMA and N-mustard, has selective toxicity to drug sensitive and drug resistant leukemia cells and solid tumors | Lee, C. H.; Chou, T. C.; Su, T. L.; Yu, J.; Shao, L. E.; Yu, A. L. | Cancer Lett 276(2), 204-211 | | | |
| 2013 | Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer | Huang, Y. -L.; Hung, J. -T.; Cheung, S. K. C.; Lee, H. -Y.; Chu, K. -C.; Li, S. -T.; Lin, Y. -C.; Ren, C. -T.; Cheng, T. -J. R.; Hsu, T. -L.; Yu, A. L.; Wu, C. -Y.; Wong, C. -H. | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 110(7), 2517-22 | | | |
| 2013 | Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer. | Huang, Y. -L.; Hung, J. -T.; Cheung, S. K. C.; Lee, H. -Y.; Chu, K. -C.; Li, S. -T.; Lin, Y. -C.; Ren, C. -T.; Cheng, T. -J. R.; Hsu, T. -L.; Yu, A. L.; Wu, C. -Y.; Wong, C. -H. | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 110(7), 2517-22 | | | |
| 1989 | Characterization of the potentiation effect of activin on human erythroid colony formation in vitro | Yu, J.; Shao, L.; Vaughan, J.; Vale, W.; Yu, A. L. | Blood 73, 952-960 | | | |
| 2007 | Charge-monitoring laser-induced acoustic desorption mass spectrometry for cell and microparticle mass distribution measurement | Peng, W. P.; Lin, H. C.; Lin, H. H.; Chu, M.; Yu, A. L.; Chang, H. C.; Chen, C. H. | ANGEWANDTE CHEMIE-INTERNATIONAL EDITION 46(21), 3865-3869 | | | |
| 1994 | Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia | Diccianni, M. B.; Yu, J.; Mukherjee, S.; Shao, L. E.; Yu, A. L. | Blood 84, 3105-3112 | | | |
| 2009 | Controversial Issues and Debates about Cancer Stem Cells | Yu, J.; Fu, C. H.; Chang, W. W.; Yu, A. L. | | | | |
| 1996 | Exploitation of frequent p16 deletion in the treatment of T cell acute lymphoblastic leukemia | Yu, A. L.; Chen, J.; Diccianni, M. B.; Batova, A.; Yu, J | In: Molecular Biology of Hematopoiesis 5, Nader G. Abraham, S. Asano, G. Brittenger, R. Shadduck (eds.), Plenum Press, New York 247-256 | | | |
| 1997 | Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia (T-ALL) | Batova, A.; Diccianni, M. B.; Yu, J. C.; Nobori, T.; Link, M. P.; Pullen, J.; Yu, A. L. | Cancer Res 57, 832-836 | | | |
| 1996 | Frequent delection in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: Strategies for enzyme-targeted therapy | Batova, A.; Diccianni, M. B.; Nobori, T.; Vu, T.; Yu, J.; Bridgeman, L.; Yu, A. L. | Blood 88, 3083-3090 | | | |
| 2007 | High-speed mass analysis of whole erythrocytes by charge-detection quadrupole ion trap mass spectrometry | Nie, Z. X.; Cui, F. P.; Tzeng, Y. -K.; Chang, H. -C.; Chu, M.; Lin, H. -C.; Chen, C. -H.; Lin, H. -H.; Yu, A. L. | Anal. Chem. 79, 7401-7407 | | | |
| 2009 | Higher expression of SHIP2 contributes to maintenance and tumorigenecity of human breast cancer stem cells | Fu, C. H; Chang, W. W; Chang, W. Y; Hsu, C. W; Yeo, H. L; Yu, J. C; Shao, L. E; Yu, J; Yu, A. L. | | | | |
| 2000 | Human cord blood conditioned medium enhances leukemia colony formation in vitro | Shao, L. E.; Dialynas, D. P.; Yu, A. L.; Mackintosh, E.; Yu, J. | Leukemia. Res 24, 1041-1048 | | | |
| 2007 | Human p16gamma, a novel transcriptional variant of p16INK4A, co-expresses with p16INK4A in cancer cells and inhibits cell cycle progression | Lin, Y. C.; Diccianni, M. B.; Kim, Y.; Lin, H. H.; Lee, C. H.; Lin, R. J.; Joo, S. H.; Li, J.; Chuang, T. J.; Yang, A. S.; Kuo, H. H.; Tsai, M. D.; Yu, A. L. | Oncogene 26(49), 7017-7027 | | | |
| 2006 | Identification of slow cycling, OCT-4+ stem/progenitor cells from mouse lung tissues. | Ling, T. Y.; Yu, A. L.; Yu, J. | | | | |
| 2009 | IGF-IR/AKT/mTOR pathway is important for maintenance of Breast cancer stem cells. | Chang, W. W; Yu, J; Fu, C. H; Lai, C. Y; Shao, L. E; Yu, J. C; Yu, A. L. | | | | |
